In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Arnaud Rosier, the CEO and founder of Implicity. He offers insights on his company’s technology, which enables the remote monitoring of implanted cardiac devices. Dr. Rosier speaks about working with the device makers as well as the physicians using his software. He also speaks to the value of remote monitoring during the pandemic. Specifically, the following questions are addressed.

• Why did you create Implicity and what does the company do?
• Do you partner with device makers or are you able to collect the data without their buy-in?
• What are the challenges with remote monitoring and did we see more emerge during the pandemic?
• What needs to happen within the reimbursement space before remote monitoring and data management solutions are likely to change?
• How do you respond to concerns over data privacy with a solution like yours?

Listen to this episode and see what you think of the remote monitoring of cardiac devices. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at [email protected].

Send us a text

For more medtech news and information, visit www.mpomag.com.